Sophie Patzek1, Heidemarie W MacMaster2, Esther Rov-Ikpah3, Craig San Luis4, Craig Johnson5, Venkateswarlu Juttukonda6, Robert J Rushakoff1. 1. Division of Endocrinology and Metabolism, University of California, San Francisco, CA, USA. 2. Department of Pharmacy, Lahey Hospital and Medical Center, Burlington, MA, USA. 3. Institute for Nursing Excellence, University of California, San Francisco, CA, USA. 4. Department of Clinical Systems, University of California, San Francisco, CA, USA. 5. Department of Health Informatics, University of California, San Francisco, CA, USA. 6. Department of Clinical Applications & Analytics, University of California, San Francisco, CA, USA.
Abstract
BACKGROUND: Perioperative diabetes patients are often treated with sliding-scale insulin, despite a lack of evidence to support therapeutic effectiveness. We introduced an automated subcutaneous insulin algorithm (SQIA) to improve glycemic control in these patients while maintaining the simplicity of a q4 hour adjustable sliding-scale insulin order set. METHODS: In this pilot study, we implemented a fully programmed, self-adjusting SQIA as part of a structured order set in the electronic medical record for adult patients who are nil per os, or on continuous enteral tube feedings or total parenteral nutrition. The nurse only enters the current glucose in the Medication Administration Record, and then the calculated dose is shown. The new dose is based on previous dose, and current and previous glucoses. The SQIA titrates the glucose to 120-180 mg/dL. For this pilot, this order set was utilized for complex perioperative oncologic patients. RESULTS: The median duration on the SQIA was 58 hours. Glucoses at titration initiation were highest at 206 ± 63 mg/dL, and came down to 156 ± 29 mg/dL by 72 hours. The majority of measured glucoses (66.8%, n = 647) were maintained between 80 and 180 mg/dL. There were no glucoses lower than 60 mg/dL, and only 0.3% (n = 3) were below 70 mg/dL. There was a low rate of errors (1%). CONCLUSIONS: A simple automated SQIA can be used to titrate insulin to meet the changing metabolic requirements of individuals perioperatively and maintain glucose within the target range for these hospitalized patients.
BACKGROUND: Perioperative diabetes patients are often treated with sliding-scale insulin, despite a lack of evidence to support therapeutic effectiveness. We introduced an automated subcutaneous insulin algorithm (SQIA) to improve glycemic control in these patients while maintaining the simplicity of a q4 hour adjustable sliding-scale insulin order set. METHODS: In this pilot study, we implemented a fully programmed, self-adjusting SQIA as part of a structured order set in the electronic medical record for adult patients who are nil per os, or on continuous enteral tube feedings or total parenteral nutrition. The nurse only enters the current glucose in the Medication Administration Record, and then the calculated dose is shown. The new dose is based on previous dose, and current and previous glucoses. The SQIA titrates the glucose to 120-180 mg/dL. For this pilot, this order set was utilized for complex perioperative oncologic patients. RESULTS: The median duration on the SQIA was 58 hours. Glucoses at titration initiation were highest at 206 ± 63 mg/dL, and came down to 156 ± 29 mg/dL by 72 hours. The majority of measured glucoses (66.8%, n = 647) were maintained between 80 and 180 mg/dL. There were no glucoses lower than 60 mg/dL, and only 0.3% (n = 3) were below 70 mg/dL. There was a low rate of errors (1%). CONCLUSIONS: A simple automated SQIA can be used to titrate insulin to meet the changing metabolic requirements of individuals perioperatively and maintain glucose within the target range for these hospitalized patients.
Entities:
Keywords:
hospital diabetes; hyperalimentation diabetes; inpatient diabetes; nil per os diabetes
Authors: Ahmed N Al-Niaimi; Mostafa Ahmed; Nikki Burish; Saygin A Chackmakchy; Songwon Seo; Stephen Rose; Ellen Hartenbach; David M Kushner; Nasia Safdar; Laurel Rice; Joseph Connor Journal: Gynecol Oncol Date: 2014-09-28 Impact factor: 5.482
Authors: A Pezzarossa; F Taddei; M C Cimicchi; E Rossini; S Contini; E Bonora; A Gnudi; E Uggeri Journal: Diabetes Care Date: 1988-01 Impact factor: 19.112
Authors: J J Pomposelli; J K Baxter; T J Babineau; E A Pomfret; D F Driscoll; R A Forse; B R Bistrian Journal: JPEN J Parenter Enteral Nutr Date: 1998 Mar-Apr Impact factor: 4.016
Authors: Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr Journal: J Thorac Cardiovasc Surg Date: 2003-05 Impact factor: 5.209